Searchable abstracts of presentations at key conferences in endocrinology

ea0025p173 | Endocrine tumours and neoplasia | SFEBES2011

Adenosine receptors modulate chromogranin A secretion and growth of neuroendocrine tumours: potential targets for therapy

Kalhan Atul , Garibi Borzo , Jasani Bharat , Kidd Mark , Modlin Irvin , Pfragner Roswitha , Rees Aled , Ham Jack

Introduction: Neuroendocrine tumors of GI tract are a heterogeneous group of rare neoplasms that secrete peptides and amines. These tumors are highly vascular and their vascularity reflects increased tumour related angiogenesis. Adenosine, a major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.Material and methods: The expression of adenosine receptors (AR) was investigated in two human n...

ea0046p1 | (1) | UKINETS2016

MicroRNAs associated with small bowel neuroendocrine tumours and their metastases

Miller Helen C , Frampton Adam E , Malczewska Anna , Ottaviani Silvia , Stronach Euan A , Flora Rashpal , Kaemmerer Daniel , Schwach Gert , Pfragner Roswitha , Faiz Omar , Kos-Kudla Beata , Hanna George B , Stebbing Justin , Castellano Leandro , Frilling Andrea

Introduction: Novel molecular analytes are needed in small bowel neuroendocrine tumours (SBNETs) to better determine disease aggressiveness and predict treatment response.Aim of the study: To profile the global miRNome of SBNETs, and identify microRNAs (miRNAs) involved in tumour progression for use as potential biomarkers.Material and methods: Two independent miRNA profiling experiments were performed (n=90), including pr...

ea0063p665 | Interdisciplinary Endocrinology 1 | ECE2019

CD27-IgD- memory B cells studied in polycystic ovary syndrome

Ascani Angelo , Gumpold Roswitha , Borzan Valentin , Flieszer Elisabeth , Weber Jennifer , Prietl Barbara , Helmut Stradner Martin , Obermayer-Pietsch Barbara

Background: Age-associated double negative (DN) B memory cells lacking surface expression of CD27 and IgD have been associated with proinflammatory characteristics, higher disease activity in autoimmune diseases and disease-specific autoantibodies. We studied the distribution of DN B cells in Polycystic Ovary Syndrome (PCOS), their surface markers and cytokine production.Methods: CD19+ cell subpopulations on the basis of IgD and CD27 expression were phen...

ea0016p818 | Thyroid | ECE2008

Clinical evaluation of 3rd generation assay for thyrotropin receptor autoantibodies in autoimmune thyroid diseases

Schott Matthias , Graeber Claudia , Domberg Julia , Charko Roswitha , Hermsen Derik , Schinner Sven , Scherbaum Werner A , Willenberg Holger S

Recently a new procedure for measuring serum TSH receptor (TSHR) autoantibody (TRAb) was reported in which the autoantibodies inhibit binding of a human monoclonal thyroid stimulating antibody M22 (labeled with biotin) to TSHR-coated ELISA plate wells. This assay was termed 3rd generation TRAb assay. The aim of the present study was to clinically evaluate the TRAb 3rd generation assay in comparison with the 2nd generation TRAb assay (TRAb-2nd) based on the recombinant human TS...

ea0019p176 | Endocrine tumours and neoplasia | SFEBES2009

Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours

Kalhan A , Vazquez M , Jasani B , Stott J , Neal J , Gharibi B , Kidd M , Modlin I , Pfragner R , Rees D , Ham J

Neuroendocrine tumors (NETs) of GI tract are a heterogeneous group of neoplasms that secrete peptides and amines. Small bowel NETs originate from enterochromaffin (EC) cells and secrete chromogranin A (CgA) and serotonin (5-HT). NETs are highly vascular, a reflection of increased tumour related angiogenesis. Adenosine, the major regulator of angiogenesis, is released by enhanced degradation of ATP, during cellular stress, damage and hypoxia.Aims: Aims of...